<DOC>
	<DOCNO>NCT00598832</DOCNO>
	<brief_summary>The purpose study determine whether Adapalene , 0.1 % safe effective treatment Acne Vulgaris .</brief_summary>
	<brief_title>Clinical Study Test Efficacy Safety Adapalene , 0.1 %</brief_title>
	<detailed_description>This study compare efficacy safety Adapalene , 0.1 % vehicle treatment subject Acne Vulgaris . This multi-center , randomize , double-blind , parallel , vehicle control study involve subject acne vulgaris meeting pre-specified inclusion/exclusion criterion . Male female subject , 12 year age old , 20-50 papule pustules 30 100 non-inflammatory lesion Investigator 's Global Assessment ( IGA ) score 3 ( Moderate ) 4 ( Severe ) eligible enrollment . One nodule may present inclusion . Acne lesion evaluate face . Subjects present facial truncal acne vulgaris participate study . Subjects randomize 1:1 ratio Adapalene , 0.1 % Vehicle .</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Adapalene</mesh_term>
	<criteria>Subjects Moderate Severe Acne Vulgaris , 2050 papule pustule total face exclude nose 30100 noninflammatory lesion face exclude nose . Negative urine pregnancy test female . Subjects one acne nodule . Subjects acne cyst face . Subjects acne conglobata , acne fulminans , secondary acne ( chloracne , druginduced acne , etc . ) , severe acne require systemic treatment . Subjects underlying disease dermatologic condition require use interfering topical systemic therapy , , limit , atopic dermatitis , perioral dermatitis rosacea . Subjects pregnant , nursing , plan pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2011</verification_date>
	<keyword>Acne Vulgaris</keyword>
	<keyword>Adapalene</keyword>
</DOC>